title: Recurrent endometrial stromal sarcoma: treatment with a progestin and gonadotropin releasing hormone agonist.
abstract: Endometrial stromal sarcoma (ESS) formerly classified as low-grade endometrial stromal sarcoma is a rare uterine malignancy with a good prognosis despite a tendency to recur. Primary surgical management for ESS includes total abdominal hysterectomy and bilateral salpingo-oophorectomy. Patients with ESS have long disease-free survival rates when treated with primary surgical therapy, but nearly fifty percent of these patients will recur. We present the case of a patient with recurrent ESS who had an excellent response to combined therapy with megestrol and leuprolide.
authors.affiliation: Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California, Irvine College of Medicine, Orange, CA 92868, USA.
authors.forename: Nefertiti Chianti
authors.initials: NC
authors.lastname: Dupont
authors.forename: Philip John
authors.initials: PJ
authors.lastname: Disaia